Daniel Char - Nov 30, 2022 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
SVP & CHIEF LEGAL OFFICER
Signature
/s/ Renee Lentini, Attorney-in-Fact
Stock symbol
IMGN
Transactions as of
Nov 30, 2022
Transactions value $
$2,076,000
Form type
4
Date filed
11/30/2022, 04:16 PM
Previous filing
Nov 30, 2022
Next filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (Right to Buy) Award $2.08M +400K $5.19 400K Nov 30, 2022 Common Stock 400K $5.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.